ArticlePharmaceutics2024

GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics.

Karim Obeid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.